These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18540170)

  • 1. Synthesis and biological activity of dipeptides containing S-hexylcysteine.
    Bruzgo I; Midura-Nowaczek K
    Acta Pol Pharm; 2007; 64(5):479-82. PubMed ID: 18540170
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide.
    Lee K; Park CW; Jung WH; Park HD; Lee SH; Chung KH; Park SK; Kwon OH; Kang M; Park DH; Lee SK; Kim EE; Yoon SK; Kim A
    J Med Chem; 2003 Aug; 46(17):3612-22. PubMed ID: 12904065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site.
    Tucker TJ; Lumma WC; Mulichak AM; Chen Z; Naylor-Olsen AM; Lewis SD; Lucas R; Freidinger RM; Kuo LC
    J Med Chem; 1997 Mar; 40(6):830-2. PubMed ID: 9083470
    [No Abstract]   [Full Text] [Related]  

  • 4. 1-Aminoisoquinoline as benzamidine isoster in the design and synthesis of orally active thrombin inhibitors.
    Rewinkel JB; Lucas H; van Galen PJ; Noach AB; van Dinther TG; Rood AM; Jenneboer AJ; van Boeckel CA
    Bioorg Med Chem Lett; 1999 Mar; 9(5):685-90. PubMed ID: 10201829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of benzylamides of dipeptides as potential inhibitors of plasmin.
    Midura-Nowaczek K; Roszkowska-Jakimiec W; Lepietuszko I; Bruzgo I
    Pharmazie; 2003 Oct; 58(10):687-9. PubMed ID: 14609277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of alkylamides of dipeptides as potential plasmin inhibitors.
    Midura-Nowaczek K; Lepietuszko I; Bruzgo I
    Acta Pol Pharm; 2006; 63(1):33-7. PubMed ID: 17515327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new class dipeptide analogues with improved permeability and antithrombotic activity.
    Zhao M; Bi L; Bi W; Wang C; Yang Z; Ju J; Peng S
    Bioorg Med Chem; 2006 Jul; 14(14):4761-74. PubMed ID: 16616499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic aspects of the development of selective synthetic thrombin inhibitors as anticoagulants.
    Hauptmann J; Markwardt F
    Semin Thromb Hemost; 1992; 18(2):200-17. PubMed ID: 1631568
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of lactobionic acid on the kinetics of thrombin in human plasma.
    Béguin SS; Dol F; Hemker HC
    Semin Thromb Hemost; 1991; 17 Suppl 1():126-8. PubMed ID: 2068565
    [No Abstract]   [Full Text] [Related]  

  • 10. Structure and synthesis of WB-3559 A, B, C and D, new fibrinolytic agents isolated from Flavobacterium sp.
    Uchida I; Yoshida K; Kawai Y; Takase S; Itoh Y; Tanaka H; Kohsaka M; Imanaka H
    Chem Pharm Bull (Tokyo); 1985 Jan; 33(1):424-7. PubMed ID: 4006031
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new generation of anticoagulants: design, synthesis and pharmacologic profile of thrombin inhibtors].
    Schmid G; Ackermann J; Banner D; Gast A; Gubernator K; Hadváry P; Hilpert K; Labler L; Tschopp T
    J Pharm Belg; 1995; 50(2-3):188-93. PubMed ID: 7674118
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on WB-3559 A, B, C and D, new potent fibrinolytic agents. II. Structure elucidation and synthesis.
    Uchida I; Yoshida K; Kawai Y; Takase S; Itoh Y; Tanaka H; Kohsaka M; Imanaka H
    J Antibiot (Tokyo); 1985 Nov; 38(11):1476-86. PubMed ID: 4077727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARC-1779, a PEGylated aptamer antagonist of von Willebrand factor for potential use as an anticoagulant or antithrombotic agent.
    Cosmi B
    Curr Opin Mol Ther; 2009 Jun; 11(3):322-8. PubMed ID: 19479665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (3S)-N-(L-Aminoacyl)-1,2,3,4-tetrahydroisoquinolines, a class of novel antithrombotic agents: synthesis, bioassay, 3D QSAR, and ADME analysis.
    Zheng M; Zhang X; Zhao M; Chang HW; Wang W; Wang Y; Peng S
    Bioorg Med Chem; 2008 Nov; 16(21):9574-87. PubMed ID: 18835178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antithrombotic drugs.
    Gross PL; Weitz JI
    Clin Pharmacol Ther; 2009 Aug; 86(2):139-46. PubMed ID: 19553932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the fibrinolytic, anti-coagulative, thrombolytic and hemorheologic action of Lumbricus].
    Zhang D; Chen B
    Zhong Yao Cai; 2003 Jun; 26(6):448-51. PubMed ID: 14666947
    [No Abstract]   [Full Text] [Related]  

  • 17. How drugs act-17. Drugs and the blood.
    Smith SE
    Nurs Times; 1975 Oct; 71(42):1665-6. PubMed ID: 1196926
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.
    Wang G; Goyal N; Hopkinson B
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3798-803. PubMed ID: 19447619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis & hypoglycemic activity of arginine peptides.
    Mathur KB; Kishore V; Srivastava RC; Mukherjee SK
    Indian J Biochem Biophys; 1980 Aug; 17(4):303-5. PubMed ID: 7216250
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of molecular weight of chemically sulfated citrus pectin fractions on their antithrombotic and bleeding effects.
    Cipriani TR; Gracher AH; de Souza LM; Fonseca RJ; Belmiro CL; Gorin PA; Sassaki GL; Iacomini M
    Thromb Haemost; 2009 May; 101(5):860-6. PubMed ID: 19404539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.